Wall Street Analysts Predict a 407.94% Upside in Precision BioSciences (DTIL): Here's What You Should Know

Shares of Precision BioSciences (DTIL) have gained 23% over the past four weeks to close the last trading session at $15.37, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $78.07 indicates a potential upside of 407.9%.The average comprises five short-term price targets ranging from a low of $30.03 to a high of $150.15, with a standard deviation of $45.55. While the lowest estim ...